We Sell 100% ORIGINAL Books ONLY.

Pharmocracy (Hb) at Meripustak

Pharmocracy (Hb) by KAUSHIK SUNDAR RAJAN, Orient Blackswan Pvt. Ltd.

Books from same Author: KAUSHIK SUNDAR RAJAN

Books from same Publisher: Orient Blackswan Pvt. Ltd.

Related Category: Author List / Publisher List

  • Price: ₹ 1495.00/- [ 5.00% off ]

    Seller Price: ₹ 1420.00

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Estimated Delivery Time : 08-Oct-2022

Click for International Orders
  • We deliver across all postal codes in India

  • MeriPustak’s books are 100 % New & Original copy
  • General Information  
    PublisherOrient Blackswan Pvt. Ltd.
    Publish YearJanuary 2017


    Orient Blackswan Pvt. Ltd. Pharmocracy (Hb) by KAUSHIK SUNDAR RAJAN

    In this book, Kaushik Sunder Rajan introduces the concept of “pharmocracy” to explain the structure and operation of the global, multinational pharmaceutical industry. He highlights pharmocracy's logic in two case studies from contemporary India: the controversial introduction of an HPV vaccine in 2010, and the Indian Patent Office's denial of a patent for an anticancer drug in 2006 and the ensuing legal battles. In each instance, health was appropriated by capital and transformed from a state of well-being into an abstract category dependent on capital's interests. These cases demonstrate the precarious situation in which pharmocracy places both health and democracy, as India's accommodation of global pharmaceutical regulatory frameworks puts the interests of its citizens against those of international capital. Continuing Sunder Rajan’s theoretical explorations into the relationships among biosciences, the market, and political economy, Pharmocracy contributes to debates in the humanities and social sciences around questions of health, law, and political economy. It will be of interest to anthropologists, sociologists, historians, and political theorists, as well as to legal scholars, public health practitioners, policymakers and pharmaceutical industry analysts.